Skip to main content
ISTH 2023 Main banner
Back

    Anna M. Randi, MD PhD (she/her/hers)

    Professor of Cardiovascular Medicine
    Imperial College London
    London, England, United Kingdom

    Anna Randi is Professor of Cardiovascular Medicine and Head of Vascular Science at the National Heart and Lung Institute, Imperial College London, UK. Her research interests are in vascular biology and haemostasis, and the overlap between the two. Major discoveries from the Randi lab have defined the transcriptional and epigenetic mechanisms controlling vascular integrity, endothelial cell homeostasis and resilience to disease. The group identified von Willebrand factor as a regulator of angiogenesis, by multiple approaches including circulating endothelial progenitors from patients’ blood (ECFC). These studies opened the way to new understanding of mechanisms underlying intractable bleeding in VWD, identified novel therapeutic targets and inspired others to explore these pathways, and to study ECFC in VWD and other bleeding disorders.
    Anna Randi is a clinically qualified haematologist, specialized in haemostasis and thrombosis. She trained with Prof. Mannucci at the University of Milan (Italy) and with Dr. Sadler at Washington University, St. Louis (USA); here she was involved in the first characterization of mutations in the von Willebrand factor gene. She moved to the UK to study endothelial biology and vascular diseases, first at GlaxoSmithKline and then at Imperial College London, where she set up her lab in 2003. In 2022 she was Visiting Professors at The University of Milan, Italy.
    Anna Randi serves on national and international review panels. She was on the Editorial Board of Blood and is Strategic Editor of Bleeding Thrombosis and Vascular Biology (BTVB). From 2013 to 2017 she was Secretary of the European Vascular Biology organisation (EVBO). She was the Scientific Chair (Basic Research) for the London 2022 ISTH meeting; she is a Fellow of the American Heart Association (FAHA). Anna Randi is committed to promoting the careers of young researchers, providing a supportive and stimulating working environment for all, with particular focus on gender equality.

    Presentation(s):